ClariVest Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

ClariVest Asset Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-161	Closed	-$6K	–	682
2015 Q1	$6K	Sell	161 -191	-54%	-$7.36K	﹤0.01%	502
2014 Q4	$12K	Sell	352 -7,400	-95%	-$261K	﹤0.01%	457
2014 Q3	$271K	Hold	7,752	–	–	0.01%	332
2014 Q2	$255K	Sell	7,752 -132	-2%	-$4.52K	0.01%	341
2014 Q1	$291K	Buy	7,884 +7,462	+1,768%	+$274K	0.01%	321
2013 Q4	$17K	Buy	422 +70	+20%	+$2.21K	﹤0.01%	486
2013 Q3	$10K	Sell	352 -100	-22%	-$2.37K	﹤0.01%	473
2013 Q2	$9K	Buy	+452	New	+$8.82K	﹤0.01%	446

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

ClariVest Asset Management's WX Position: Q2 2015 in Review

ClariVest Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 161 shares — an estimated $6K sold.

ClariVest Asset Management first reported a position in WX in Q2 2013 and held it in 8 quarters. The position peaked at $291K in Q1 2014. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

ClariVest Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
ClariVest Asset Management sold 161 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $6K.
ClariVest Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 8 quarters.
ClariVest Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $291K in Q1 2014.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on ClariVest Asset Management's 13F filing for Q2 2015, filed 27 Jul 2015.